Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial (vol 16, pg 87, 2015)

Oza A. M.; Cibula D.; Benzaquen A. O.

首页> 外文期刊>The lancet oncology >Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial (vol 16, pg 87, 2015)

【24h】

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial (vol 16, pg 87, 2015)

机译：奥拉帕里布联合化疗治疗复发的铂敏感型卵巢癌：一项随机的2期临床试验（第16卷，第87页，2015年）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The lancet oncology》 |2015年第2期|共1页
作者
Oza A. M.; Cibula D.; Benzaquen A. O.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial (vol 16, pg 87, 2015) [J] . Oza A. M., Cibula D., Benzaquen A. O. The lancet oncology . 2015,第2期

机译：奥拉帕里布联合化疗治疗复发的铂敏感型卵巢癌：一项随机的2期临床试验（第16卷，第87页，2015年）
2. Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial [J] . Oza Amit M., Cibula David, Oaknin Benzaquen Ana, The lancet oncology . 2015,第1期

机译：奥拉帕里布联合化疗治疗复发的铂敏感型卵巢癌：一项随机的2期临床试验
3. CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-Sensitive Ovarian Cancer [J] . Jung-Min Lee, Jane B. Trepel, Peter Choyke, Frontiers in Oncology . 2015,第4期

机译：CECs和IL-8具有复发性铂敏感卵巢癌患者的预后和预测效用：生物标志物与奥拉帕里布的随机相位-2试验与反复性铂敏感卵巢癌中的奥拉帕里布相比相关
4. Phase I trial of motexafin-lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer [C] . Diana C. Stripp, Rosemarie Mick, Timothy C. Zhu, Conference on optical methods for tumor treatment and detection: Mechanisms and techniques in photodynamic therapy . 2004

机译：Matexafin-Lutetium介导的患者局部复发前列腺癌患者的术语I阶段试验
5. Combining Optical Tweezers and Quantitative Phase Imaging for Interrogating the Mechanical Properties of Ovarian Cancer Cells and Erythrocyte Derived Microparticles [D] . Lu, Thompson. 2020

机译：结合光学镊子和定量相位成像，用于询问卵巢癌细胞和红细胞衍生微粒的机械性能
6. CECs and IL-8 Have Prognostic and Predictive Utility in Patients with Recurrent Platinum-Sensitive Ovarian Cancer: Biomarker Correlates from the Randomized Phase-2 Trial of Olaparib and Cediranib Compared with Olaparib in Recurrent Platinum-Sensitive Ovarian Cancer [O] . Jung-Min Lee, Jane B. Trepel, Peter Choyke, 2015

机译：CECs和IL-8在复发性铂敏感性卵巢癌患者中具有预后和预测效用：生物标志物与Olaparib和Cediranib的随机2期随机试验相比与Olaparib在复发性铂敏感性卵巢癌中的相关性
7. CECs and IL-8 have prognostic and predictive utility in patients with recurrent platinum-sensitive ovarian cancer: biomarker correlates from the randomized phase 2 trial of olaparib and cediranib compared with olaparib in recurrent platinum-sensitive ovarian cancer [O] . Jung-Min eLee, Jane B. Trepel, Peter eChoyke, 2015

机译：CECs和IL-8在复发性铂敏感性卵巢癌患者中具有预后和预测效用：生物标志物与olaparib和西地尼布与复发性铂敏感性卵巢癌中olaparib的随机2期试验相关

Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial (vol 16, pg 87, 2015)

著录项

相似文献

相关主题

期刊订阅